These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17107823)

  • 1. What's happening - Scotblood 2006 advances in immunetolerance, information technology, microarrays and pathogen inactivation in transfusion medicine.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2006 Oct; 35(2):173-7. PubMed ID: 17107823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scotblood 2012: transfusion/transplant medicine in the 2nd decade of the 21st century.
    Colligan D; McGowan N; Seghatchian J
    Transfus Apher Sci; 2013 Jun; 48(3):415-20. PubMed ID: 23643474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scotblood 2010: key presentations of the past, present, and future of transfusion medicine to mark Scottish national blood transfusion service (SNBTS) anniversaries.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2011 Oct; 45(2):213-21. PubMed ID: 21840760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal use of blood and innovative approaches to stem cells, regenerative medicine and donor recruitment.
    Colligan D; McGowan N; Seghatchian J
    Transfus Apher Sci; 2014 Apr; 50(2):303-6. PubMed ID: 24642068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's happening: Scotblood 2005. The donor, the product, the patient: how are we shaping up for the 21st century?
    Bessos H; Seghatchian J
    Transfus Apher Sci; 2006 Apr; 34(2):227-32. PubMed ID: 16516553
    [No Abstract]   [Full Text] [Related]  

  • 6. Scotblood 2007: Tackling local and global issues in transfusion medicine - donor recruitment, effective use of blood, stem cell plasticity, and vCJD.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2008 Feb; 38(1):77-83. PubMed ID: 18282808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scotblood 2008 celebrates 60th anniversary of the NHS through past, present, and future of transfusion medicine, encompassing Hepatitis C Scottish Odyssey, nursing, translational medicine and trauma.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2008 Dec; 39(3):261-8. PubMed ID: 18929514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scotblood 2015: Improving and delivering blood products, novel cellular therapies, and celebrating patients and donor engagement within transfusion services.
    Colligan D; McGowan N; Seghatchian J
    Transfus Apher Sci; 2016 Aug; 55(1):164-8. PubMed ID: 27524267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative research, improving quality, and celebrating patient successes and the role of donors within transfusion services.
    Colligan D; McGowan N; Seghatchian J
    Transfus Apher Sci; 2015 Feb; 52(1):48-53. PubMed ID: 25639736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XIII Annual Scientific Meeting of the British Blood Transfusion Society and Scotblood 1995. Stirling, United Kingdom, 1-4 September 1995. Abstracts.
    Transfus Med; 1995 Sep; 5 Suppl 1():1-59. PubMed ID: 7581729
    [No Abstract]   [Full Text] [Related]  

  • 11. Scotblood 2011 features advances in translational medicine, haemopoietic progenitor cells and milestones of blood banking systems.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2011 Dec; 45(3):315-20. PubMed ID: 22033500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCOTBLOOD 2009: the quest for understanding vCJD; Claudia's Trachea implantation; transfusion triggers; Scottish histocompatibility and immunogenetics network; and islet cell transplantation.
    Bessos H; Fraser R; Seghatchian J
    Transfus Apher Sci; 2010 Feb; 42(1):89-95. PubMed ID: 20089457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Academic Bio of the Senior Guest Editor: Dr Jerard Seghatchian.
    Seghatchian J
    Transfus Apher Sci; 2016 Aug; 55(1):9. PubMed ID: 27522104
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evolution of transfusion risks in 15 years (1987-2002)].
    Rouger P
    Rev Infirm; 2005 Mar; (109):22-5. PubMed ID: 15853075
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosketch: Jerard Seghatchian.
    Seghatchian J
    Transfus Apher Sci; 2011 Aug; 45(1):27-8. PubMed ID: 21737350
    [No Abstract]   [Full Text] [Related]  

  • 16. What's new in the blood crisis?
    Mackenzie CF
    Br J Hosp Med (Lond); 2009 Jan; 70(1):6. PubMed ID: 19357569
    [No Abstract]   [Full Text] [Related]  

  • 17. [Challenges of transfusion medicine].
    Hervé P; Tiberghien P
    Rev Prat; 2001 Jun; 51(12):1337-40. PubMed ID: 11503508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion medicine in the era of proteomics.
    Liumbruno G; D'Amici GM; Grazzini G; Zolla L
    J Proteomics; 2008 Apr; 71(1):34-45. PubMed ID: 18541472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the professional practices of physicians in transfusion technology and medicine].
    Hergon E; Py JY; Jullien S; Quaranta JF; Folléa G; Andreu G; Cabaud JJ; Staccini P; Rouger P
    Transfus Clin Biol; 2007 Aug; 14(3):371-7. PubMed ID: 17604672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in transfusion policies?
    Vincent JL; Hajjar LA
    Intensive Care Med; 2013 Jun; 39(6):1002-4. PubMed ID: 23571871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.